Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y T Chan

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|January 3, 2015
Allergy in Hong Kong: an unmet need in service provision and trainingY T Chan, H K Ho, Christopher K W Lai, et al.
Cancers|August 14, 2019
ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast CancersTarek M A Abdel-Fatah, Reem Ali, Maaz Sadiq, et al.
British Journal of Cancer|April 24, 2014
HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancerT M A Abdel-Fatah, S E B McArdle, C Johnson, et al.
Oncology Reports|January 5, 2007
Ethyl acetate extract of Chinese medicinal herb Sarcandra glabra induces growth inhibition on human leukemic HL-60 cells, associated with cell cycle arrest and up-regulation of pro-apoptotic Bax/Bcl-2 ratioW Y Li, Lawrence C M Chiu, W S Lam, et al.
Nanoscale Advances|June 16, 2025
RNA lipid nanoparticles stabilized during nebulization through excipient selectionKai V Slaughter, Daniela Isaacs-Bernal, Eric N Donders, et al.
International Ophthalmology|April 15, 2014
Optic neuritis in Hong Kong: a 1-year follow-up studyPatrick P K Lau, Gordon S K Yau, Jacky W Y Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancerNicholas J Robert, Véronique Diéras, John Glaspy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression AnalysisTarek M A Abdel-Fatah, Stephanie E B McArdle, Devika Agarwal, et al.
Clinical Transplantation|June 1, 1997
Highly successful long-term outcome of kidney transplantation in Chinese recipients: an enhancing race effect?B R Hawkins, P Chan, Y T Chan, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 26, 2022
Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial SystemRoy Pattipeiluhu, Gabriela Arias-Alpizar, Genc Basha, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|January 3, 2015
Allergy in Hong Kong: an unmet need in service provision and trainingY T Chan, H K Ho, Christopher K W Lai, et al.
Cancers|August 14, 2019
ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast CancersTarek M A Abdel-Fatah, Reem Ali, Maaz Sadiq, et al.
British Journal of Cancer|April 24, 2014
HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancerT M A Abdel-Fatah, S E B McArdle, C Johnson, et al.
Oncology Reports|January 5, 2007
Ethyl acetate extract of Chinese medicinal herb Sarcandra glabra induces growth inhibition on human leukemic HL-60 cells, associated with cell cycle arrest and up-regulation of pro-apoptotic Bax/Bcl-2 ratioW Y Li, Lawrence C M Chiu, W S Lam, et al.
Nanoscale Advances|June 16, 2025
RNA lipid nanoparticles stabilized during nebulization through excipient selectionKai V Slaughter, Daniela Isaacs-Bernal, Eric N Donders, et al.
International Ophthalmology|April 15, 2014
Optic neuritis in Hong Kong: a 1-year follow-up studyPatrick P K Lau, Gordon S K Yau, Jacky W Y Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancerNicholas J Robert, Véronique Diéras, John Glaspy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression AnalysisTarek M A Abdel-Fatah, Stephanie E B McArdle, Devika Agarwal, et al.
Clinical Transplantation|June 1, 1997
Highly successful long-term outcome of kidney transplantation in Chinese recipients: an enhancing race effect?B R Hawkins, P Chan, Y T Chan, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 26, 2022
Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial SystemRoy Pattipeiluhu, Gabriela Arias-Alpizar, Genc Basha, et al.
Pageof 13